IL1B and inflammatory bowel disease: To determine whether CCLE mitigates acute IBD through its anti-inflammatory effects, we measured the serum levels of pro-inflammatory cytokines, including IL-6, TNF-α, and IL-1β, as well as colon myeloperoxidase (MPO) using ELISA.